Fibroblast growth factor receptor: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 12: | Line 12: | ||
[[1fgk]], [[3kxx]], [[3ky2]] – hFGFR1 TKD (mutant) - human <br /> | [[1fgk]], [[3kxx]], [[3ky2]] – hFGFR1 TKD (mutant) - human <br /> | ||
[[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]] – hFGFR1 TKD (mutant) + inhibitor <br /> | [[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]], [[4nk9]], [[4nka]], [[4nks]] – hFGFR1 TKD (mutant) + inhibitor <br /> | ||
[[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br /> | [[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br /> | ||
[[1xr0]] – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR<br /> | [[1xr0]] – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR<br /> | ||
| Line 35: | Line 35: | ||
[[1gjo]], [[1oec]], [[2psq]] – hFGFR2 TKD <br /> | [[1gjo]], [[1oec]], [[2psq]] – hFGFR2 TKD <br /> | ||
[[2pvy]], [[2pwl]], [[2py3]], [[2pz5]], [[2pzp]], [[2pzr]], [[2q0b]] – hFGFR2 TKD (mutant) + ACP<br /> | [[2pvy]], [[2pwl]], [[2py3]], [[2pz5]], [[2pzp]], [[2pzr]], [[2q0b]], [[4j95]], [[4j96]], [[4j97]], [[4j98]], [[4j99]] – hFGFR2 TKD (mutant) + ACP<br /> | ||
[[3b2t]] – hFGFR2 TKD (mutant) + adenosine derivative<br /> | [[3b2t]] – hFGFR2 TKD (mutant) + adenosine derivative<br /> | ||
[[2pvf]] – hFGFR2 TKD with PTR + ACP + substrate peptide<br /> | [[2pvf]] – hFGFR2 TKD with PTR + ACP + substrate peptide<br /> | ||
| Line 44: | Line 44: | ||
[[3dar]], [[3caf]], [[3euu]] – hFGFR2 LBD D2 <br /> | [[3dar]], [[3caf]], [[3euu]] – hFGFR2 LBD D2 <br /> | ||
[[1wvz]] – hFGFR2 LBD D2 - NMR<br /> | |||
[[4hwu]] – hFGFR2 LBD D1 <br /> | [[4hwu]] – hFGFR2 LBD D1 <br /> | ||
| Line 52: | Line 53: | ||
[[1djs]] – hFGFR2 LBD D2,D3 (mutant) + hFGF1 <br /> | [[1djs]] – hFGFR2 LBD D2,D3 (mutant) + hFGF1 <br /> | ||
[[1ev2]], [[1ii4]], [[1iil]] – hFGFR2 LBD D2,D3 + hFGF2 (mutant) <br /> | [[1ev2]], [[1ii4]], [[1iil]] – hFGFR2 LBD D2,D3 + hFGF2 (mutant) <br /> | ||
[[4j23]] – hFGFR2 LBD D2,D3 (mutant) + hFGF2 (mutant) + inhibitor <br /> | |||
[[3cu1]] – hFGFR2 LBD D2 + hFGF1 <br /> | [[3cu1]] – hFGFR2 LBD D2 + hFGF1 <br /> | ||
[[2fdb]] – hFGFR2 LBD D2,D3 + hFGF8b <br /> | [[2fdb]] – hFGFR2 LBD D2,D3 + hFGF8b <br /> | ||
| Line 59: | Line 61: | ||
[[3grw]] – hFGFR3 LBD D2,D3 + antibody<br /> | [[3grw]] – hFGFR3 LBD D2,D3 + antibody<br /> | ||
[[2lzl]] – hFGFR3 residues 357-399 – NMR<br /> | |||
[[4k33]] – hFGFR3 kinase domain (mutant)<br /> | |||
''FGFR3 complex with FGF'' | ''FGFR3 complex with FGF'' | ||